Article Details

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 18.5% in August

Retrieved on: 2022-08-31 08:48:32

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 18.5% in August. View article details on HISWAI: https://reporter.am/2022/08/31/akebia-therapeutics-inc-nasdaqakba-short-interest-down-18-5-in-august.html

Excerpt

AQR Capital Management LLC now owns 862,168 shares of the biopharmaceutical company's stock valued at $304,000 after purchasing an additional 677,703 ...

Article found on: reporter.am

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up